Cargando…

Dose Prescription Methods in Stereotactic Body Radiotherapy for Small Peripheral Lung Tumors: Approaches Based on the Gross Tumor Volume Are Superior to Prescribing a Dose That Covers 95% of the Planning Target Volume

BACKGROUND AND PURPOSE: We aimed to validate the usefulness of prescriptions based on gross tumor volume for stereotactic body radiotherapy for small peripheral lung tumors. MATERIALS AND METHODS: Radiotherapy treatment planning data of 50 patients with small peripheral lung tumors (adenocarcinoma:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komiyama, Takafumi, Saito, Masahide, Kuriyama, Kengo, Marino, Kan, Aoki, Shinichi, Saito, Ryo, Muramatsu, Juria, Maehata, Yoshiyasu, Ze, Chen, Akita, Tomoko, Yamada, Takashi, Sano, Naoki, Yoshizawa, Kazuya, Kazunari, Ashizawa, Hidekazu, Suzuki, Ueda, Koji, Vu, Nam, Onishi, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720311/ https://www.ncbi.nlm.nih.gov/pubmed/33272112 http://dx.doi.org/10.1177/1533033820974030

Ejemplares similares

Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy
por: Funayama, Satoshi, et al.
Publicado: (2019)

Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy
por: Saito, Masahide, et al.
Publicado: (2020)

Comparison of MLC error sensitivity of various commercial devices for VMAT pre‐treatment quality assurance
por: Saito, Masahide, et al.
Publicado: (2018)

Tumor volume shrinkage during stereotactic body radiotherapy is related to better prognoses in patients with stage I non-small-cell lung cancer
por: Vu, Nam, et al.
Publicado: (2020)

Approach to dose definition to the gross tumor volume for lung cancer with respiratory tumor motion
por: Miura, Hideharu, et al.
Publicado: (2013)

Intrafractional setup errors in patients undergoing non-invasive fixation using an immobilization system during hypofractionated stereotactic radiotherapy for lung tumors
por: Watanabe, Meguru, et al.
Publicado: (2013)

Prognosticating Gross Tumor Volume in Head-and-Neck Cancer – Redefining Gross Tumor Volume Beyond Contouring
por: Ahmed, Imtiaz, et al.
Publicado: (2023)

Quantification of image quality of intra-fractional cone-beam computed tomography for arc irradiation with various imaging condition
por: Saito, Masahide, et al.
Publicado: (2021)

Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity
por: Onishi, Hiroshi, et al.
Publicado: (2020)

Impact of Systemic Autoimmune Diseases on Treatment Outcomes and Radiation Toxicities in Patients with Stage I Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy: A Matched Case-Control Analysis
por: Chen, Zhe, et al.
Publicado: (2022)

Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective study
por: Chen, Zhe, et al.
Publicado: (2021)

Anatomy-based prediction method for determining ipsilateral lung doses in postoperative breast radiation therapy assisted by diagnostic computed tomography images
por: Chen, Zhe, et al.
Publicado: (2022)

Immune Responses following Stereotactic Body Radiotherapy for Stage I Primary Lung Cancer
por: Maehata, Yoshiyasu, et al.
Publicado: (2013)

Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patients
por: Nambu, Atsushi, et al.
Publicado: (2011)

Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors
por: Nambu, Atsushi, et al.
Publicado: (2013)

Stereotactic Body Radiotherapy for Localized Ureter Transitional Cell Carcinoma: Three Case Reports
por: Maehata, Yoshiyasu, et al.
Publicado: (2015)

Optimal Clinical Target Volume of Radiotherapy Based on Microscopic Extension around the Primary Gross Tumor in Non-Small-Cell Lung Cancer: A Systematic Review
por: Tamaki, Yukihisa, et al.
Publicado: (2022)

Usefulness of double dose contrast-enhanced magnetic resonance imaging for clear delineation of gross tumor volume in stereotactic radiotherapy treatment planning of metastatic brain tumors: a dose comparison study
por: Subedi, Kalloo Sharma, et al.
Publicado: (2013)

Deep Learning for Automated Contouring of Gross Tumor Volumes in Esophageal Cancer
por: Jin, Linzhi, et al.
Publicado: (2022)

Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patients
por: Peng, Hao, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy for Metachronous Multisite Oligo-Recurrence: A Long-Surviving Case with Sequential Oligo-Recurrence in Four Different Organs Treated Using Locally Radical Radiotherapy and a Review of the Literature
por: Onishi, Hiroshi, et al.
Publicado: (2012)

Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer
por: Kajitani, Chikae, et al.
Publicado: (2013)

Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer
por: Chen, Yuanmei, et al.
Publicado: (2021)

Interobserver variability in gross tumor volume contouring in non-spine bone metastases
por: de la Pinta, Carolina, et al.
Publicado: (2022)

Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report
por: Nonaka, Hotaka, et al.
Publicado: (2017)

Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: reducing interobserver variation
por: Toya, Ryo, et al.
Publicado: (2019)

Author Index for Volume 95
Publicado: (2006)

Keyword Index for Volume 95
Publicado: (2006)

Chair Heterogeneity Index: Describing the dose heterogeneity inside the tumor volume where there is a boost volume
por: Mu, Jinming, et al.
Publicado: (2018)

Evaluation of Multisource Adaptive MRI Fusion for Gross Tumor Volume Delineation of Hepatocellular Carcinoma
por: Cheung, Andy Lai-Yin, et al.
Publicado: (2022)

An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
por: Morén, Björn, et al.
Publicado: (2019)

Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer
por: Zhang, Ying, et al.
Publicado: (2013)

Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy
por: Zhang, Cui-Dai, et al.
Publicado: (2021)

Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report
por: Onishi, Hiroshi, et al.
Publicado: (2014)

MRI to delineate the gross tumor volume of nasopharyngeal cancers: which sequences and planes should be used?
por: Popovtzer, Aron, et al.
Publicado: (2014)

Deep learning for segmentation of the cervical cancer gross tumor volume on magnetic resonance imaging for brachytherapy
por: Rodríguez Outeiral, Roque, et al.
Publicado: (2023)

Subject Index to Volumes 86-95
Publicado: (1989)

Cumulative index 1984–1988 volume 86 through volume 95
Publicado: (1989)

Effect of tumor and normal lung volumes on the lung volume–dose parameters of IMRT in non–small-cell lung cancer
por: Zou, Xi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7cgl46m7fjubrj7k17r2ortmhu